ProMetic confirms PBI-4050's Anti-Fibrotic Effect in Nash Model and on Human Hepatic Stellate Cells

ProMetic confirms PBI-4050’s Anti-Fibrotic Effect in Nash Model and on Human Hepatic Stellate Cells

April 14, 2016

Down regulation of fibrotic biomarkers in human hepatic stellate cells (HHSC); key cells involved in liver fibrosis.
PBI-4050 significantly reduces liver fibrosis in NASH model.

LAVAL, QC, April 14, 2016 /CNW Telbec/ – ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF)…

» View More News for April 14, 2016